Metoprolol-Z Retard Al (Metoprolol Tartrate)

Metoprolol tartrate selectively blocks β1‑adrenergic receptors in the heart. By inhibiting the effects of adrenaline and noradrenaline, it slows the heart rate, lowers contractile force, and reduces the speed of electrical conduction. These actions decrease cardiac output and arterial pressure, and lower the heart’s oxygen demand.

The appropriate dose of Metoprolol‑Z Retard Al is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and any co‑existing health issues. Dosage adjustments may be required for renal impairment or elderly patients, and the regimen should always follow the prescriber’s instructions.

Safety data for metoprolol tartrate in pregnancy are limited, and the drug is generally classified as use‑only if the potential benefit justifies the potential risk to the fetus. It is excreted in breast milk, so a healthcare professional should evaluate the risk‑benefit balance before use during lactation.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Metoprolol tartrate is a β1‑selective blocker, offering cardiac‑focused effects with less impact on bronchial β2 receptors compared with non‑selective agents like propranolol. This selectivity can make it preferable for patients with respiratory concerns, though individual response and tolerability vary, and choice of therapy should be guided by the treating physician.

Store Metoprolol‑Z Retard Al at ambient temperature, preferably below 25 °C. Keep the tablets in their original packaging, protect them from moisture, heat and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Metoprolol‑Z Retard Al is taken orally, usually with or without food, as directed by the prescriber. Tablets should be swallowed whole with a glass of water and not crushed or chewed, unless a specific formulation advises otherwise.

Serious risks include severe bradycardia, heart block, marked hypotension, bronchospasm in susceptible individuals, and rare allergic reactions such as angioedema. Patients should be monitored for these events, especially when initiating therapy or adjusting the dose.

Metoprolol‑Z Retard Al is contraindicated in patients with known hypersensitivity to metoprolol or other β‑blockers, those with severe bradycardia, second‑ or third‑degree heart block without a pacemaker, and individuals with uncompensated heart failure or cardiogenic shock. Caution is also advised for patients with severe asthma or chronic obstructive pulmonary disease.